Contact
searchSearch
HMP Global

December 2012 - FRMC

Biomarker Changes in Alzheimer Disease
12/17/2012
Alzheimer disease (AD) is the most common cause of dementia and currently affects about 5 million Americans. By 2050, this number is expected to increase to 13 million.
Alzheimer disease (AD) is the most common cause of dementia and currently affects about 5 million Americans. By 2050, this number is expected to increase to 13 million.
Alzheimer disease (AD) is the...
12/17/2012
First Report Managed Care
Inhibition of HIV-1 Disease Progression
12/17/2012
Two important human lentiviruses have been described: (1) pandemic HIV type 1 (HIV-1), and (2) HIV type 2 (HIV-2), which is mainly confined to West Africa. Both viruses have similar transmission routes, cellular targets, and AIDS-defining...
Two important human lentiviruses have been described: (1) pandemic HIV type 1 (HIV-1), and (2) HIV type 2 (HIV-2), which is mainly confined to West Africa. Both viruses have similar transmission routes, cellular targets, and AIDS-defining...
Two important human lentiviruses...
12/17/2012
First Report Managed Care
Administration of Telaprevir Twice or 3 Times Daily
12/17/2012
Boston—Patients with hepatitis C had similar sustained virologic response rates after 12 weeks whether they took 1125 mg of telaprevir twice daily or 750 mg of telaprevir every 8 hours, according to a randomized, open-label, multicenter,...
Boston—Patients with hepatitis C had similar sustained virologic response rates after 12 weeks whether they took 1125 mg of telaprevir twice daily or 750 mg of telaprevir every 8 hours, according to a randomized, open-label, multicenter,...
Boston—Patients with hepatitis C...
12/17/2012
First Report Managed Care
Boceprevir Pharmacokinetics
12/17/2012
Boston—An analysis of clinical trials found that co-infected patients had a reduction in boceprevir exposure compared with mono-infected patients with hepatitis C. The authors noted the difference likely occurred because of an interaction...
Boston—An analysis of clinical trials found that co-infected patients had a reduction in boceprevir exposure compared with mono-infected patients with hepatitis C. The authors noted the difference likely occurred because of an interaction...
Boston—An analysis of clinical...
12/17/2012
First Report Managed Care
Hospitalization and Costs Lower with Aripiprazole
12/17/2012
San Diego—A retrospective cohort analysis of medical and pharmacy claims data from 24 state Medicaid plans found that schizophrenia patients newly treated with the atypical antipsychotic (AA) aripiprazole had lower hospitalization rates and...
San Diego—A retrospective cohort analysis of medical and pharmacy claims data from 24 state Medicaid plans found that schizophrenia patients newly treated with the atypical antipsychotic (AA) aripiprazole had lower hospitalization rates and...
San Diego—A retrospective cohort...
12/17/2012
First Report Managed Care
Vilazodone Well Tolerated in Treatment of MDD
12/17/2012
San Diego—Data from 2 pivotal trials of 891 patients demonstrated that vilazodone was significantly superior to placebo on all depression rating scales tested, according to results presented during a poster session at the Psych Congress. The...
San Diego—Data from 2 pivotal trials of 891 patients demonstrated that vilazodone was significantly superior to placebo on all depression rating scales tested, according to results presented during a poster session at the Psych Congress. The...
San Diego—Data from 2 pivotal...
12/17/2012
First Report Managed Care
Benefits of Wellness Programs, On-Site Care Services
12/17/2012
Las Vegas—Research presented during a session at the Fall Managed Care Forum showed that employers, employees, and health plans can benefit from implementing wellness programs, managing chronic conditions such as diabetes, and having on-site...
Las Vegas—Research presented during a session at the Fall Managed Care Forum showed that employers, employees, and health plans can benefit from implementing wellness programs, managing chronic conditions such as diabetes, and having on-site...
Las Vegas—Research presented...
12/17/2012
First Report Managed Care
Biologic DMARDs for Rheumatoid Arthritis
12/17/2012
Las Vegas—Soon after patients are diagnosed with rheumatoid arthritis (RA), they experience symptoms, and, within 2 years, they have a moderate loss of function that can contribute to health problems, lost work time, and other issues. To...
Las Vegas—Soon after patients are diagnosed with rheumatoid arthritis (RA), they experience symptoms, and, within 2 years, they have a moderate loss of function that can contribute to health problems, lost work time, and other issues. To...
Las Vegas—Soon after patients...
12/17/2012
First Report Managed Care

Department

Conference Insider
Session Discusses Effective Insomnia Management
12/17/2012
San Diego—Insomnia is prevalent in the general population and quite common among people with mental health disorders. Approximately 50 to 70 million Americans suffer from chronic sleep disorders that adversely affect daily functioning,...
San Diego—Insomnia is prevalent in the general population and quite common among people with mental health disorders. Approximately 50 to 70 million Americans suffer from chronic sleep disorders that adversely affect daily functioning,...
San Diego—Insomnia is prevalent...
12/17/2012
First Report Managed Care
Conference Insider
Combination Therapy for ADHD Shows Promise
12/17/2012
San Diego—Combination therapy has been used informally in mental health, but new evidence is emerging that combination therapy is safe and effective for difficult and treatment-resistant cases of attention-deficit hyperactivity disorder...
San Diego—Combination therapy has been used informally in mental health, but new evidence is emerging that combination therapy is safe and effective for difficult and treatment-resistant cases of attention-deficit hyperactivity disorder...
San Diego—Combination therapy...
12/17/2012
First Report Managed Care
FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

What's Trending?

News
Improving, Optimizing Treatment for Migraine
11/16/2018
During a session at the Scottsdale Headache Symposium 2018, Michael Ready, MD, FAHS, discussed how to develop an effective migraine preventative plan.
During a session at the Scottsdale Headache Symposium 2018, Michael Ready, MD, FAHS, discussed how to develop an effective migraine preventative plan.
During a session at the...
11/16/2018
First Report Managed Care
News
CMS report: Reforms will save Medicare nearly $8 billion through next year
08/03/2010
08/03/2010
First Report Managed Care
Department
Costs Similar Among Multiple Myeloma Patients Treated With Kyprolis vs Pomalyst
01/23/2017
According to recent research presented at the 2016 ASH Annual Meeting and Exposition, multiple myeloma treatment costs are not significantly different when using Kyprolis (carfilzomib; Amgen) compared to treatment with Pomalyst (pomalidomide;...
According to recent research presented at the 2016 ASH Annual Meeting and Exposition, multiple myeloma treatment costs are not significantly different when using Kyprolis (carfilzomib; Amgen) compared to treatment with Pomalyst (pomalidomide;...
According to recent research...
01/23/2017
First Report Managed Care
News
Medicare Releases Patient Safety Ratings For Hospitals
12/06/2011
12/06/2011
First Report Managed Care
News
Cardiovascular Risk Scores Overestimate Likelihood of Cardiovascular Events
02/16/2015
Four of 5 common cardiovascular risk scores overestimate the likelihood of cardiovascular events by as much as 115%, researchers report.
Four of 5 common cardiovascular risk scores overestimate the likelihood of cardiovascular events by as much as 115%, researchers report.
Four of 5 common cardiovascular...
02/16/2015
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

December 2012 Volume 9 Issue 12

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use